236 related articles for article (PubMed ID: 9987921)
1. Globoid cell leukodystrophy in cairn and West Highland white terriers.
Wenger DA; Victoria T; Rafi MA; Luzi P; Vanier MT; Vite C; Patterson DF; Haskins MH
J Hered; 1999; 90(1):138-42. PubMed ID: 9987921
[TBL] [Abstract][Full Text] [Related]
2. Cloning of the canine GALC cDNA and identification of the mutation causing globoid cell leukodystrophy in West Highland White and Cairn terriers.
Victoria T; Rafi MA; Wenger DA
Genomics; 1996 May; 33(3):457-62. PubMed ID: 8661004
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate.
Luzi P; Rafi MA; Victoria T; Baskin GB; Wenger DA
Genomics; 1997 Jun; 42(2):319-24. PubMed ID: 9192853
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of globoid cell leukodystrophy in Irish setters.
McGraw RA; Carmichael KP
Vet J; 2006 Mar; 171(2):370-2. PubMed ID: 16490723
[TBL] [Abstract][Full Text] [Related]
5. Genetic galactocerebrosidase deficiency (globoid cell leukodystrophy, Krabbe disease) in rhesus monkeys (Macaca mulatta).
Baskin GB; Ratterree M; Davison BB; Falkenstein KP; Clarke MR; England JD; Vanier MT; Luzi P; Rafi MA; Wenger DA
Lab Anim Sci; 1998 Oct; 48(5):476-82. PubMed ID: 10090061
[TBL] [Abstract][Full Text] [Related]
6. Retroviral vector-mediated transfer of the galactocerebrosidase (GALC) cDNA leads to overexpression and transfer of GALC activity to neighboring cells.
Rafi MA; Fugaro J; Amini S; Luzi P; de Gala G; Victoria T; Dubell C; Shahinfar M; Wenger DA
Biochem Mol Med; 1996 Aug; 58(2):142-50. PubMed ID: 8812733
[TBL] [Abstract][Full Text] [Related]
7. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
Shin D; Feltri ML; Wrabetz L
J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications.
Wenger DA; Rafi MA; Luzi P
Hum Mutat; 1997; 10(4):268-79. PubMed ID: 9338580
[TBL] [Abstract][Full Text] [Related]
9. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
[TBL] [Abstract][Full Text] [Related]
10. Murine, canine and non-human primate models of Krabbe disease.
Wenger DA
Mol Med Today; 2000 Nov; 6(11):449-51. PubMed ID: 11074371
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid and serum glycosphingolipid biomarkers in canine globoid cell leukodystrophy (Krabbe Disease).
Corado CR; Pinkstaff J; Jiang X; Galban EM; Fisher SJ; Scholler O; Russell C; Bagel JH; ODonnell PA; Ory DS; Vite CH; Bradbury AM
Mol Cell Neurosci; 2020 Jan; 102():103451. PubMed ID: 31794880
[TBL] [Abstract][Full Text] [Related]
12. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
[TBL] [Abstract][Full Text] [Related]
13. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
14. Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).
Bradbury AM; Bagel JH; Jiang X; Swain GP; Prociuk ML; Fitzgerald CA; O'Donnell PA; Braund KG; Ory DS; Vite CH
J Neurosci Res; 2016 Nov; 94(11):1007-17. PubMed ID: 27638585
[TBL] [Abstract][Full Text] [Related]
15. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease).
Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA
Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
17. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease.
Iacono D; Koga S; Peng H; Manavalan A; Daiker J; Castanedes-Casey M; Martin NB; Herdt AR; Gelb MH; Dickson DW; Lee CW
Neurobiol Dis; 2022 Nov; 174():105862. PubMed ID: 36113749
[TBL] [Abstract][Full Text] [Related]
18. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease.
Harzer K; Knoblich R; Rolfs A; Bauer P; Eggers J
Clin Chim Acta; 2002 Mar; 317(1-2):77-84. PubMed ID: 11814461
[TBL] [Abstract][Full Text] [Related]
19. Novel genetic variant associated with globoid cell leukodystrophy in a family of mixed breed dogs.
Hammack S; Hague DW; Vieson MD; Esdaile E; Hughes SS; Bellone RR; McCoy AM
J Vet Intern Med; 2023; 37(5):1710-1715. PubMed ID: 37593836
[TBL] [Abstract][Full Text] [Related]
20. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model.
Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL
Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
